ESSO 2020 VIRTUAL
Reshaping Surgical Oncology after COVID-19
Friday 23 October 2020, 16:00 - 21:00 CEST
Saturday 24 October 2020, 09:00 - 13:00 CEST
ESSO is highly appreciative of the continued support of our industry partners. We thank them for their involvement in bringing the ESSO 2020 Virtual experience online.
Committed to the best science, we strive to reduce uncertainty when choosing a breast cancer treatment path. Our genomic tests support treatment decisions. Our flagship is the risk of recurrence test: MammaPrint. Our additional test is BluePrint for molecular subtyping. Together we can improve the lives of breast cancer patients.
Agendia Satellite Symposium - Friday 23rd October 19:20 - 19:50 CEST
Title: How does genomic profiling impact your breast cancer surgery?
Speakers: Prof. Dr. Emiel J.T. Rutgers, MD, PhD, FRCS
Isabel T. Rubio, MD, PhD, FEBS, FSSO
Hologic is an innovative medical technology company whose purpose is to enable healthier lives everywhere, every day. While we discover and develop ground-breaking products and services that benefit everyone, we are especially passionate about those that advance women’s health and well-being. We are also a company that prospers and grows, which is why we have been able to expand our offerings to benefit even more people and champion women’s health. Hologic’s advanced portfolio dedicated to breast conserving surgeries, allows for efficiencies in the OR, between radiologists, surgeons, and pathologists, with solutions that better the patient experience.
Hologic Satellite Symposium - Saturday 24th October 11:05 - 11:35 CEST
Wire-free Localization for surgery of non-palpable breast lesions with LOCalizerTM radiofrequency identification (RFID) tags : our experience from the first 150 cases
- Dr. Robert Milligan (Consultant Oncoplastic Breast surgeon, Queen Elizabeth Hospital Gateshead NHS, UK)
The use of wire-free localization techniques is emerging as a new standard for optimizing the planning and realization of surgical removal of impalpable breast lesions. Several different alternatives to traditional wire-localization exist. In this webinar the results from over 150 procedures with a RFID tag (LOCalizer) will be presented and the resulting clinical experience will be shared. The webinar will also include a questions and answers section which will allow participants to ask questions to the presenter.
-Learn about the use of LOCalizer (RFID) tags for breast surgery of non-palpable breast lesions.
- Appreciate the added value, challenges and limitations of using the RFID tags.
- Understand the potential value of RFID tags and the impact on clinical routine.
- Become familiar with typical clinical situations where LOCalizer have added value.
S.I.T. – Sordina IORT Technologies S.p.A. is leader in manufacturing IOeRT Linacs, Treatment Planning Systems and FLASH research systems to develop and produce new technological solutions to fight against cancer.
We are operating in every continent, with current installations, business units, distributors and field engineers of IOeRT and FLASH systems combining with pre-clinical research accelerators.
S.I.T. Satellite Symposium - Saturday 24th October 09:50 - 10:20 CEST
Topic: IOeRT Clinical Guidelines & Applications and Groundbreaking Technological Developments
- Prof. Felipe Calvo Manuel
- Dr. Isabel Rubio
- Dr. Philip Poortmans
“IOeRT, an introduction for surgeons”
"IOeRT in breast cancer, the surgeon’s practical viewpoint"
"IOeRT for other tumours, the sarcoma example”
“Presentation of the ESTRO-ACROP guidelines”
Sysmex supports healthcare professionals around the world in lighting the way with diagnostics by providing a broad range of medical diagnostics products and solutions. In the fields of haematology, urinalysis, haemostasis, life science, flow cytometry and essential healthcare, we combine highly dependable, multi-functional and easy-to-operate instruments, a variety of reagents and software, plus reliable service and support.
Sysmex Europe GmbH, located near Hamburg, Germany, is a subsidiary of the Sysmex Corporation from Kobe, Japan. From our Hamburg offices, we serve our affiliates, distributors and customers throughout Europe, the Middle East, and Africa (EMEA). For more information on how we are lighting the way with diagnostics, visit www.sysmex-europe.com/lifescience.
Sysmex Satellite Symposium - Friday 23rd October 16:50 – 17:20 CEST
- Prof. Dr. Marc Thill (Head of Department of Gynecology and Gynecological Oncology, Agaplesion Markus Hospital, Frankfurt am Main, Germany): Magseed® as long-term marker for target lymph nodes during neoadjuvant therapy – first experiences and perspectives
- Dr. med. Maria Margarete Karsten (Leitende Oberärztin Senologie, Klinik für Gynäkologie mit Brustzentrum, Berlin, Germany): Using Magtrace® and Magseed® to improve the care process and comfort for breast cancer patients and their treatment providers
Since 1896, Nutricia has pioneered nutritional solutions that help people live longer, more joyful and healthier lives. Building on more than a century of research and innovation, Nutricia has harnessed the power of life-changing and life-saving nutrition to create a leading specialized nutrition portfolio that can change a health trajectory for life.
With its nutritional solutions, Nutricia supports healthy growth and development during the first 1000 days and helps to address some of the world’s health challenges including conditions such as frailty, cancer, stroke and early Alzheimer’s disease.
Nutricia is part of Danone, a global leader with a unique health-focused portfolio in food and beverages.
Session supported by Nutricia - Saturday 24th October 11:35 - 12:05 CEST
Title: Medical nutrition along the surgical oncology patient’s journey (cross specialty session)
Chair: Sergio Sandrucci, IT
Co-chair: Wim Ceelen, BE
Moderator: Yvonne Schrage, NL
Speakers: Luca Nespoli, IT: Perioperative Nutritional Support of oncologic surgical Patients in the Age of ERAS
Alessandro Laviano, IT: Clinical Value of Nutritional Status in Cancer surgery: can Disease Progression and Prognosis be affected?
Sirius Medical has its roots firmly embedded in the surgical clinic. Developing technology by and for clinicians, we were born to make things better. We improve healthcare for cancer patients through our effective, affordable localization system, enabling the precise and efficient surgical removal of tumors.
Sirius Medical recently received CE mark for their Sirius Pintuition system and has started its commercial launch in September 2020 in most European countries.
To learn more about Sirius Pintuition and the Sirius Medical, visit www.sirius-medical.com.
Sirius Medical Systems Satellite Workshop - Friday 23rd October 18:20 - 18:35 CEST
First clinical results: “Safety and performance of Sirius Pintuition“ – a novel wire-free and nonradioactive localization system for breast cancer surgery - Speaker Dr. Maud Bessems, Surgeon Oncologist Jeroen Bosch Hospital, Den Bosch, The Netherlands
Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook and Instagram.
Contact Person: Martina Volz
Phone: +49 89 5383-0
Elsevier is a global information analytics business that helps institutions and professionals progress science, advance healthcare and improve performance. As the world´s leading provider of science and health information, Elsevier serves more than 30 million scientists, students and health and information professionals worldwide. Find out more on www.elsevier.com.
OLYMPUS, as a worldwide leading manufacturer of cutting edge Advanced Energy devices as well as sophisticated Imaging systems, aims to provide innovative and safe products striving to be the most valuable partner for specialists in the field of General Surgery. Working closely with Health Care Professionals every day, Olympus mission is to continuously find the best solutions for our customers and to improve the outcomes for patients and society. Our first responsibility is to enhance the wellbeing of patients, the working environment for doctors and nursing staff to make people’s lives healthier, safer and more fulfilling.
Thompson Surgical Instruments, Inc.
Thompson Surgical celebrates 55 years as a leader in exposure and the original manufacturer of the table-mounted retractor. We understand the value of exposure in surgery and are dedicated to providing innovative, high quality systems that deliver safe, versatile, and low-profile retraction. From pediatric to obesity, simple to complex exposures, we offer unlimited customization and safe, independent, retraction. The Thompson Retractor provides Uncompromised Exposure for all types of oncology procedures.